Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06238700 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06238700 · ClinicalTrials.gov record · last posted 2026-08-26

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

Name: Study on Allopregnanolone and Depression in Women Across the Menopause Transition — clinical trial record (NCT06238700)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SADIE-P

StatusRecruiting

PhaseNot applicable

SponsorBeth Israel Deaconess Medical Center

Started2026-05-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study aims to identify how enhanced allopregnanolone activity (via pregnenolone) affects behavior and neurobiology that may underlie perimenopausal depression.

Protocol amendment history 2 changes detected by DataLookout

2026-08-27

Primary completion pushed: 2027-07-31 → 2027-12-01

2026-08-27

Completion pushed: 2027-08-31 → 2027-12-31

Trial Details

NCT Number	NCT06238700
Lead Sponsor	Beth Israel Deaconess Medical Center
Conditions	Depression
Enrollment	80 participants
Start Date	2026-05-01
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-26